Skip to content
★ Sign in to follow
MH

Mitchell H. Finer

Executive
Adverum Biotechnologies, Inc.bluebird bio, Inc.
Total declarations
82
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (58 ops.)
€20.6M

Latest filing published 14 Jun 2017 for Adverum Biotechnologies, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
58
Signal history

No signal scores available.

Mitchell H. Finer: trading record in brief

Mitchell H. Finer discloses dealings in 2 companies, chiefly bluebird bio, Inc. and Adverum Biotechnologies, Inc. Over a trading history stretching from 16 December 2013 to 12 June 2017, the count stands at 82 filings.

No open-market purchase appears, only 58 sales worth €20.6M. The rest of the record consists of 2 share grants and 22 option exercises.

The record was last updated on 14 June 2017 with a share grant in Adverum Biotechnologies, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Mitchell H. Finer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations82 total

25 of 82 declarations